When it comes to medicine, the most promising treatments may be those that already exist.
That’s why across the country, hospitals are conducting clinical trials with hundreds of existing therapeutics – therapeutics used to treat patients with other diseases – to measure their effectiveness in combating COVID-19.
For example Gilead’s promising anti-viral Remdesivir has made headlines for months, with data showing it helps shorten hospital recovery times. Now, Gilead is testing an easier-to-use inhaled version of the medicine.
Also in the pipeline to serve coronavirus patients: new drugs originally discovered to treat rheumatoid arthritis and a generic steroid that has been used for decades to treat patients suffering from everything from allergic reactions to spine and brain tumors.
These trials are happening everywhere – in 224 congressional districts and counting; in communities large and small; in hard-hit hot spots like New York City and in less affected regions like Dakota Dunes, SD.
In other words, the forefront of medical innovation might be right in your backyard. Soon, the U.S. Chamber will release a new, interactive map to show in real time where COVID-19 clinical trials are taking place throughout the United States.
We hope people will use the map to identify how they can support – and even participate in – important clinical trials. That support and participation could make all the difference in the fight against COVID-19.
–Jonathan Weinberger, Executive Vice President, GIPC, U.S. Chamber of Commerce